In Mozambique, data quality continues to be a major challenge for many facility- and community-based programs. JSI has been working closely with the country’s Ministry of Health to identify gaps in data collection and reporting so as to produce accurate, timely, and precise data. This is critical for health workers to make decisions about patient care and for broader health system actors to evaluate new and ongoing programs and ensure appropriate drug stocks.
In 2013, JSI began assessing the quality of the data collected on six key indicators related to HIV by performing data quality assessments at health facilities in Mozambique. These assessments evaluate data collected at the facility level and compare recorded data to data captured at the national level in order to determine discrepancies and improve overall data quality.
One in three women worldwide has been beaten, coerced into sex, or otherwise abused at least once in her lifetime. And women who have experienced gender-based violence (GBV) can face up to three times greater risk for HIV compared to those who have not, according to UNAIDS. GBV is common, affecting both women and men. Children and key populations are also at high risk, and often don’t have access to the resources they need.
The future of immunization supply chains in Africa was the subject of a recent discussion hosted by JSI and PATH at the Exchange of best practices workshop on Reaching Every Community (REC); Equity and Integration of Child survival interventions in East and Southern African Countries.” JSI’s Jeff Sanderson offers examples of immunization supply chains that have been effectively transformed.
Drawing from the results-based forecasting for Mozambique’s Central de Medicamentos e Artigos Médicos (CMAM) conducted by the USAID | DELIVER PROJECT, JSI’s Brian Serumaga weighs in with recommendations on how the widely contested central medical store model can be improved.